Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 12 Breast Neoplasms 11 Lung Neoplasms 6 Prostatic Neoplasms 5 Colorectal Neoplasms 5 Uterine Cervical Neoplasms 4 Thyroid Neoplasms 2 Smoking Cessation 2 Motor Activity 2 Lymphoma 2 Hematologic Neoplasms 2 Communication 2 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Tobacco Use Cessation 1 Thyroid Diseases 1 Substance-Related Disorders 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Sexual Dysfunction, Physiological 1 Sedentary Behavior 1 Rectal Neoplasms 1 Patient Preference 1 Patient Acceptance of Health Care 1 Papillomavirus Infections 1 Papillary Thyroid Microcarcinoma 1 Neoplasms, Plasma Cell 1

Interventions

Oxaliplatin 271 Fluorouracil 268 Capecitabine 234 Leucovorin 209 Irinotecan 152 Radiotherapy 138 Bevacizumab 114 Cetuximab 82 Surgical Procedures, Operative 51 Folfox protocol 48 Neoadjuvant Therapy 45 Drug Therapy 43 Radiation 42 Chemotherapy, Adjuvant 34 Chemoradiotherapy 34 Panitumumab 27 Magnetic Resonance Spectroscopy 26 XELOX 25 Radiotherapy, Intensity-Modulated 23 Biopsy 20 Surveys and Questionnaires 18 Laparoscopy 18 Proctectomy 17 Floxuridine 17 Early Intervention, Educational 16 Nivolumab 15 Immunohistochemistry 15 Gene Expression Profiling 15 Gemcitabine 15 pembrolizumab 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Focus Groups × Clear all

NCT02551471 2018-08-09

PELVICARE

University Hospital, Bordeaux

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡